1. Home
  2. SURG vs IVVD Comparison

SURG vs IVVD Comparison

Compare SURG & IVVD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SurgePays Inc.

SURG

SurgePays Inc.

HOLD

Current Price

$0.88

Market Cap

18.3M

ML Signal

HOLD

Logo Invivyd Inc.

IVVD

Invivyd Inc.

HOLD

Current Price

$1.83

Market Cap

437.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SURG
IVVD
Founded
2006
2020
Country
United States
United States
Employees
20
N/A
Industry
Advertising
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.3M
437.1M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
SURG
IVVD
Price
$0.88
$1.83
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
5
Target Price
$9.75
$8.75
AVG Volume (30 Days)
143.1K
1.6M
Earning Date
01-01-0001
06-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
79.02
EPS
N/A
N/A
Revenue
N/A
$53,426,000.00
Revenue This Year
$3.78
$143.48
Revenue Next Year
$113.46
$25.40
P/E Ratio
N/A
N/A
Revenue Growth
N/A
110.47
52 Week Low
$0.75
$0.46
52 Week High
$3.47
$3.07

Technical Indicators

Market Signals
Indicator
SURG
IVVD
Relative Strength Index (RSI) 42.69 51.65
Support Level $0.75 $1.41
Resistance Level $0.95 $2.01
Average True Range (ATR) 0.07 0.11
MACD 0.03 0.04
Stochastic Oscillator 56.89 57.32

Price Performance

Historical Comparison
SURG
IVVD

About SURG SurgePays Inc.

Surgepays Inc is a fintech company focused on the underbanked community. It provides services to financial technology, telecommunications, and digital media companies. Its operating segment includes Mobile Virtual Network Operators that provide mobile broadband (internet connectivity), voice and SMS text messaging to both subsidized and direct retail prepaid customers through SurgePhone Wireless, LLC and Torch Wireless, LLC; Comprehensive Platform Services provide financial technology and a wireless top-up platform to independently owned convenience stores throughout the country; and Others. It generates the majority of its revenue from the Mobile Virtual Network Operators segment.

About IVVD Invivyd Inc.

Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's product candidates are; ADG20 developed for the treatment and prevention of coronavirus disease, and VYD222, a monoclonal antibody candidate engineered, optimizing for potency and breadth of coverage, as well as providing a higher probability of retaining its utility for a longer duration in an evolving viral landscape.

Share on Social Networks: